Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 20, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- February 16, 2006: Transfer of 26,982 Ordinary Shares.
- February 17, 2006: Transfer of 12,962 Ordinary Shares.
These transactions were advised to the Company on February 20, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Points
- Verify the total number of shares transferred under the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period.
- Confirm the identity of the directors with interests in the GSK Trust as disclosed.
- Note that this filing does not reflect the company's operational or financial performance for the period.